New CDC director acknowledges agency problems in first large staff meeting

In her first major address to CDC staff since assuming the role of director, Dr. Erica Schwartz acknowledged ongoing challenges within the agency during a Wednesday meeting. The discussion came amid concerns over staffing shortages, burnout among employees, and the impact of recent leadership changes. Schwartz, who began her tenure at the Atlanta-based agency last week, emphasized her commitment to advocating for the CDC while addressing internal issues. Schwartz highlighted reports that some congressionally funded CDC programs are effectively nonfunctional due to staff reductions under the previous administration. These programs, referred to as “zombie” programs, lack active personnel despite having allocated funding. While she did not specify immediate actions, she pledged to engage directly with staff to understand their experiences and identify solutions. “The good news is, I’m here,” she stated, noting the difficulty of advocacy during periods of leadership instability. Prior to joining the CDC, Schwartz held roles in the U.S. Coast Guard and the U.S. Public Health Service. She described her approach to disagreement with senior officials as private, reflecting her background in uniformed services. This method ensures that professional discourse remains respectful and focused on resolving issues internally rather than publicly. She reiterated her intention to maintain this practice moving forward. The CDC has experienced a significant decline in workforce numbers, losing over 3,000 employees, more than a quarter of its total staff. This attrition has contributed to declining morale, exacerbated by frequent turnover in top leadership positions. Current and former employees noted that many front-office roles have been filled by political appointees with limited experience in public health or medicine. U.S. Health Secretary Robert F. Kennedy Jr., known for his stance against vaccines, has taken actions conflicting with CDC guidelines. These include dismantling an expert advisory committee and replacing it with a panel featuring individuals skeptical of vaccination. Such decisions have raised concerns about the influence of political ideology on public health policy. During the meeting, staff members posed questions, including one regarding Trump’s executive order revising childhood vaccine schedules. Schwartz announced the formation of a task force to examine childhood vaccine safety, though it had not convened yet. The group was given 90 days to provide findings to the president. Current and former CDC employees expressed cautious optimism about Schwartz’s leadership, acknowledging her sincerity but emphasizing the need for tangible outcomes. The National Public Health Coalition, representing former and present CDC workers, released a statement urging the agency to prioritize scientific integrity and public health interests over political pressures. As the CDC navigates these complex challenges, the coming months will likely reveal how effectively Schwartz translates her promises into actionable reforms. The agency’s ability to restore confidence and operational efficiency will depend on her capacity to balance advocacy with the demands of a politically charged environment.